Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention | Circulation
Dual antiplatelet therapy for secondary prevention of coronary artery disease | Open Heart
Dual antiplatelet therapy for acute coronary syndromes: How long to continue? | Cleveland Clinic Journal of Medicine
Antiplatelet therapy in coronary artery disease
Half‐Dose (45 mg Twice Daily) Ticagrelor Versus Clopidogrel in Neuroendovascular Dual Antiplatelet Therapy: A Single‐Center Cohort Study | Stroke: Vascular and Interventional Neurology
JCM | Free Full-Text | Escalation and De-Escalation of Antiplatelet Therapy after Acute Coronary Syndrome or PCI: Available Evidence and Implications for Practice
Dapt Review
Dual Antiplatelet Therapy Versus Aspirin in Patients With Stroke or Transient Ischemic Attack: Meta-Analysis of Randomized Controlled Trials | Stroke
JCM | Free Full-Text | Pharmacodynamics and Outcomes of a De-Escalation Strategy with Half-Dose Prasugrel or Ticagrelor in East Asians Patients with Acute Coronary Syndrome: Results from HOPE-TAILOR Trial
Antithrombotic strategies in patients undergoing early angiography.... | Download Scientific Diagram
JCM | Free Full-Text | De-Escalation of Antiplatelet Treatment in Patients with Myocardial Infarction Who Underwent Percutaneous Coronary Intervention: A Review of the Current Literature
2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy - ScienceDirect
Clinical scores for dual antiplatelet therapy (DAPT) duration... | Download Scientific Diagram
Frontiers | Dual Loading Antiplatelet Therapy in Patients With Acute Coronary Syndrome and High Bleeding Risk Undergoing Percutaneous Coronary Intervention: Findings From the Improving Care for Cardiovascular Disease in China Project
5 Pearls on Dual Antiplatelet Therapy (DAPT) | Core IM Podcast
ST 상승 급성심근경색에서 항혈소판 치료 : 네이버 블로그
Recommendations on the use and duration of dual antiplatelet therapy... | Download Scientific Diagram
![PDF] In‐Hospital Outcomes of Dual Loading Antiplatelet Therapy in Patients 75 Years and Older With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Findings From the CCC‐ACS (Improving Care for Cardiovascular Disease in](https://d3i71xaburhd42.cloudfront.net/5bd13428e7d624b55e745bd8cb17b7e61d156fa7/3-Figure1-1.png "PDF] In‐Hospital Outcomes of Dual Loading Antiplatelet Therapy in Patients 75 Years and Older With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Findings From the CCC‐ACS (Improving Care for Cardiovascular Disease in")
PDF] In‐Hospital Outcomes of Dual Loading Antiplatelet Therapy in Patients 75 Years and Older With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Findings From the CCC‐ACS (Improving Care for Cardiovascular Disease in
De-Escalation of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndromes - ScienceDirect
Dapt Review
In‐Hospital Outcomes of Dual Loading Antiplatelet Therapy in Patients 75 Years and Older With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Findings From the CCC‐ACS (Improving Care for Cardiovascular Disease in China‐Acute
Antiplatelet therapy for STEMI - ppt download
Which Antiplatelet Therapy for PCI? - ppt download
Dual Antiplatelet Therapy Versus Aspirin in Patients With Stroke or Transient Ischemic Attack: Meta-Analysis of Randomized Controlled Trials | Stroke
Figure 2 from In-Hospital Bleeding and Utility of a Maintenance Dose of Prasugrel 2.5 mg in High Bleeding Risk Patients With Acute Coronary Syndrome. | Semantic Scholar
